Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Oligodendroglioma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01378481
What this trial is testing

High-Dose Vorinostat and Fractionated Stereotactic Body Radiation Therapy in Treating Patients With Recurrent Glioma

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Giant Cell Glioblastoma+4 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT00004688
What this trial is testing

Phase II Study of Carmustine, Streptozocin, and Mercaptopurine for Refractory or Recurrent Brain Neoplasms

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligodendrogliomaMixed Gliomas+2 more
Emory University 35
Testing effectiveness (Phase 2)Study completedNCT01024907
What this trial is testing

Proton Beam Radiation Therapy in Treating Patients With Low Grade Gliomas

Who this might be right for
Adult Brain TumorAdult Brain Stem GliomaAdult Diffuse Astrocytoma+9 more
Abramson Cancer Center at Penn Medicine 23
Early research (Phase 1)WithdrawnNCT00734864
What this trial is testing

Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma

Who this might be right for
Glioblastoma MultiformeGliosarcomaAnaplastic Astrocytoma+2 more
Annick Desjardins
Early research (Phase 1)Study completedNCT01480050
What this trial is testing

Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 28
Large-scale testing (Phase 3)Study completedNCT00002840
What this trial is testing

Radiation Therapy With and Without Combination Chemotherapy in Patients With Resected Anaplastic Oligodendroglioma

Who this might be right for
Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC 350
Not applicableWithdrawnNCT02194452
What this trial is testing

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors

Who this might be right for
Acoustic SchwannomaAdult Anaplastic AstrocytomaAdult Anaplastic Ependymoma+92 more
Sue O'Dorisio
Testing effectiveness (Phase 2)Study completedNCT01026493
What this trial is testing

Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma

Who this might be right for
Brain and Central Nervous System Tumors
Radiation Therapy Oncology Group 257
Testing effectiveness (Phase 2)Study completedNCT00003134
What this trial is testing

Irinotecan in Treating Patients With Recurrent Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 64
Testing effectiveness (Phase 2)Study completedNCT00392171
What this trial is testing

The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601)

Who this might be right for
GliomaAstrocytomaOligodendroglioma+1 more
Merck Sharp & Dohme LLC 120
Early research (Phase 1)Study completedNCT00006474
What this trial is testing

Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Duke University
Testing effectiveness (Phase 2)Ended earlyNCT05737212
What this trial is testing

Studying the Safety, Efficacy, and Pharmacokinetic Characteristics of BNCT in Patients With Recurrent High-grade Gliomas

Who this might be right for
Recurrent High-grade GliomaRecurrent GlioblastomaRecurrent Anaplastic Astrocytoma+1 more
Dawonmedax Co., Ltd. 7
Early research (Phase 1)Study completedNCT01644955
What this trial is testing

Carboplatin in Treating Patients With Recurrent High-Grade Gliomas

Who this might be right for
Adult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaRecurrent Adult Brain Tumor
James Elder 10
Testing effectiveness (Phase 2)Study completedNCT00006080
What this trial is testing

Fenretinide in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Testing effectiveness (Phase 2)Study completedNCT00003574
What this trial is testing

Radiation Therapy in Treating Patients With Progressive or Recurrent Malignant Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium
Early research (Phase 1)Study completedNCT00004028
What this trial is testing

Carmustine in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT01088763
What this trial is testing

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
National Cancer Institute (NCI) 129
Early research (Phase 1)Active Not RecruitingNCT05484622
What this trial is testing

Study of Vorasidenib and Pembrolizumab Combination in Recurrent or Progressive IDH-1 Mutant Glioma

Who this might be right for
AstrocytomaOligodendroglioma
Institut de Recherches Internationales Servier 60
Testing effectiveness (Phase 2)Ended earlyNCT00003472
What this trial is testing

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Oligodendroglioma

Who this might be right for
Oligodendroglioma, Adult
Burzynski Research Institute 13
Early research (Phase 1)Study completedNCT02457845
What this trial is testing

HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors

Who this might be right for
Supratentorial Neoplasms, MalignantMalignant GliomaGlioblastoma+4 more
Gregory K. Friedman, MD 13
Next Page